Ieq Capital LLC Invests $1.87 Million in DENTSPLY SIRONA Inc. $XRAY

Posted by Brenda Bartman on Aug 26th, 2026

Ieq Capital LLC bought a new position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 176,516 shares of the medical instruments supplier’s stock, valued at approximately $1,873,000. Ieq Capital LLC owned about 0.09% of DENTSPLY SIRONA as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently bought and sold shares of the stock. Daiwa Securities Group Inc. raised its stake in DENTSPLY SIRONA by 2.9% during the fourth quarter. Daiwa Securities Group Inc. now owns 26,814 shares of the medical instruments supplier’s stock worth $306,000 after purchasing an additional 767 shares during the period. Blue Trust Inc. grew its stake in shares of DENTSPLY SIRONA by 10.8% during the 1st quarter. Blue Trust Inc. now owns 12,555 shares of the medical instruments supplier’s stock valued at $146,000 after buying an additional 1,226 shares during the period. Oregon Public Employees Retirement Fund increased its holdings in shares of DENTSPLY SIRONA by 3.3% during the 1st quarter. Oregon Public Employees Retirement Fund now owns 40,944 shares of the medical instruments supplier’s stock worth $475,000 after buying an additional 1,300 shares during the last quarter. Empowered Funds LLC increased its holdings in shares of DENTSPLY SIRONA by 8.8% during the 1st quarter. Empowered Funds LLC now owns 16,324 shares of the medical instruments supplier’s stock worth $244,000 after buying an additional 1,320 shares during the last quarter. Finally, Wilmington Savings Fund Society FSB raised its position in shares of DENTSPLY SIRONA by 13.0% in the 4th quarter. Wilmington Savings Fund Society FSB now owns 13,055 shares of the medical instruments supplier’s stock worth $149,000 after buying an additional 1,500 shares during the period. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Stock Performance

DENTSPLY SIRONA stock opened at $10.97 on Wednesday. The company has a debt-to-equity ratio of 1.48, a current ratio of 1.63 and a quick ratio of 1.07. DENTSPLY SIRONA Inc. has a 12 month low of $9.40 and a 12 month high of $14.86. The company has a fifty day moving average price of $12.05 and a two-hundred day moving average price of $11.78. The company has a market cap of $2.19 billion, a PE ratio of -3.99, a P/E/G ratio of 1.37 and a beta of 0.85.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.17. The company had revenue of $898.00 million during the quarter, compared to the consensus estimate of $889.93 million. DENTSPLY SIRONA had a negative net margin of 14.99% and a positive return on equity of 20.84%. The company’s revenue for the quarter was down 4.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.52 earnings per share. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. Research analysts expect that DENTSPLY SIRONA Inc. will post 1.41 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on XRAY shares. Weiss Ratings restated a “sell (e+)” rating on shares of DENTSPLY SIRONA in a research note on Monday, August 3rd. Barclays boosted their price objective on shares of DENTSPLY SIRONA from $9.00 to $11.00 and gave the stock an “underweight” rating in a research note on Monday. Piper Sandler raised their target price on shares of DENTSPLY SIRONA from $13.00 to $14.00 and gave the company a “neutral” rating in a research note on Wednesday, July 29th. Mizuho decreased their price target on shares of DENTSPLY SIRONA from $16.00 to $14.00 and set a “neutral” rating for the company in a research report on Wednesday, May 6th. Finally, UBS Group cut their price objective on DENTSPLY SIRONA from $18.00 to $17.00 and set a “buy” rating on the stock in a research report on Thursday, May 7th. Three research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $13.54.

Check Out Our Latest Stock Analysis on DENTSPLY SIRONA

Insider Activity

In related news, Director Brian P. Mckeon purchased 10,000 shares of the company’s stock in a transaction on Friday, June 12th. The shares were bought at an average cost of $10.12 per share, for a total transaction of $101,200.00. Following the transaction, the director owned 10,000 shares of the company’s stock, valued at $101,200. This represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. Also, Director Michael J. Barber bought 15,175 shares of the company’s stock in a transaction that occurred on Thursday, June 11th. The shares were purchased at an average cost of $9.88 per share, for a total transaction of $149,929.00. Following the acquisition, the director owned 55,943 shares of the company’s stock, valued at $552,716.84. This represents a 37.22% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last 90 days, insiders have acquired 35,160 shares of company stock valued at $351,179. Insiders own 0.46% of the company’s stock.

About DENTSPLY SIRONA

(Free Report)

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.